Contact Us

Non-Clinical and Clinical Strategy Services

Contact Us

We specialize in providing comprehensive non-clinical and clinical strategy and support as a part of our overarching regulatory strategy services. Our expert team is dedicated to ensuring that your pharmaceutical and biotechnology products not only meet rigorous regulatory standards but also achieve optimal market potential through strategic planning and meticulous support throughout the drug development process.

Foundation for Success

Our non-clinical strategy services lay the groundwork for successful drug development by integrating scientific rigor with strategic regulatory planning. We understand that the path from laboratory bench to market is fraught with complexity; hence, our approaches are designed to address these challenges head-on.

Our clinical strategy services are tailored to navigate the complexities of clinical trials and regulatory submissions. By aligning clinical research objectives with regulatory expectations, we help you streamline the path to market approval.

Comprehensive Support Includes

Country-specific CTA requirement identification and evaluation enables CTA submissions that are right the first time
Strategic guidance for successful Global Health Authority meetings
Gap Assessment and Risk Mitigation: Identification of potential non-clinical risks and development of strategies to mitigate these risks early in the development process
Development of regulatory roadmaps to accelerate development to registration timelines
Regulatory Compliance: Ensuring all aspects of the clinical trials comply with local and international regulatory standards

Seamless Engagement with Regulatory Bodies

Proactive Engagement

We pride ourselves on our proactive engagement with regulatory bodies. By anticipating regulatory shifts and understanding the nuances of regulatory expectations, we ensure that your clinical and non-clinical strategies are both compliant and competitive. Leveraging our experienced team allows for thorough preparation for Global Health Authority interactions to ensure a clear path forward for your clinical trials and product registration.

Choosing Syner-G

Means partnering with a team that understands the complexities of drug development from both a scientific and regulatory perspective. Our integrated approach ensures that your non-clinical and clinical strategies are developed with a clear understanding of the regulatory landscape, which significantly enhances the likelihood of market approval.